J&J Appeals 340B Rebate Ruling, Hospitals Laud Federal Judge’s Rejection of Drugmaker Lawsuit

Johnson & Johnson is appealing a Washington, D.C. federal district judge's ruling on the drugmaker's 340B rebate proposal.
Johnson & Johnson (J&J) has formally appealed a federal judge’s ruling that drugmakers cannot unilaterally implement a 340B rebate model—a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ohio Becomes Ninth State to Enact 340B Provider Reporting Law

Ohio Gov. Mike DeWine (R) on June 30 endorsed a state budget bill that included 340B provider reporting requirements.
Ohio Gov. Mike DeWine (R) last night endorsed a sweeping $60 billion budget bill with new 340B provider reporting requirements—but [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Verity Solutions Presents: 340B Outlook from Capitol Hill and the States

SPONSORED CONTENT

Location: Gaylord National Resort & Convention Center, Fort Washington, MD

340B stakeholders headed to the 340B Coalition Summer Conference 2025 can start their week learning the latest developments in

Read More »

Federal Judge Denies AbbVie’s Bid to Block Tennessee 340B Contract Pharmacy Access Law’s Enforcement

A Nashville federal district judge denied AbbVie's motion to block enforcement of Tennessee's 340B contract pharamacy access law.
A Nashville federal district judge on Monday denied AbbVie’s request to block enforcement of Tennessee’s new 340B contract pharmacy protections, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Reinstates Eight Sagebrush Sites into 340B Program, But Judge Rules Earlier Terminations Were Lawful

HRSA restored the 340B eligibility of eight Sagebrush sites, but a federal judge ruled that the original terminations were lawful.
The Health Resources and Services Administration (HRSA) recently reinstated eight Sagebrush sites into the 340B program—just one day before a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Alkermes, Biogen Exempt New States from 340B Contract Pharmacy Restrictions

Alkermes has added Hawaii, South Dakota and Vermont to the list of states exempted from its 340B contract pharmacy restrictions.
Two major drugmakers recently announced additional states that will no longer be subject to their 340B contract pharmacy restrictions following [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Takes Aim at 340B Program’s Growth in Pair of Op-Eds

PhRMA President and CEO Steve Ubl and Joe Grogan, a former Trump assistant and director of the White House’s Domestic Policy Council, took aim at the 340B program in a pair of recent op-eds.
The head of an influential drug industry trade group and a former Trump administration official recently called for federal 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Setting the Record Straight on 340B Growth

Ted Slafsky, publisher and CEO of 340B Report, writes about HHS Secretary Robert F. Kennedy Jr.'s controversial views on the 340B program.
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s eagerly anticipated first take on the 340B drug discount [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live